PHI and PCA3 improve the prognostic performance of PRIAS and Epstein criteria in predicting insignificant prostate cancer in men eligible for active surveillance

Decision Curve Analysis: A Novel Method for Evaluating Prediction Models

Andrew J. Vickers, Elena B. Elkin · Medical Decision Making · 2006 · 5.5K citations · Full text

Public Health, Biostatistics, Oncology +17

Long-Term Follow-Up of a Large Active Surveillance Cohort of Patients With Prostate Cancer

Laurence Klotz, Danny Vesprini, Perakaa Sethukavalan et al. · Journal of Clinical Oncology · 2014 · 1.2K citations · Full text

Medicine, Oncology, Urology +15

Clinical Results of Long-Term Follow-Up of a Large, Active Surveillance Cohort With Localized Prostate Cancer

Laurence Klotz, Liying Zhang, Adam Lam et al. · Journal of Clinical Oncology · 2009 · 1.1K citations

Medicine, Oncology, Urology +16

Active Surveillance for Low-Risk Prostate Cancer Worldwide: The PRIAS Study

Meelan Bul, Xiaoye Zhu, R. Valdagni et al. · European Urology · 2012 · 542 citations

Medicine, Oncology, Urology +16

APTIMA PCA3 Molecular Urine Test: Development of a Method to Aid in the Diagnosis of Prostate Cancer

Jack Groskopf, Sheila M. J. Aubin, Ina L. Deras et al. · Clinical Chemistry · 2006 · 531 citations · Full text

Medicine, Molecular Biology, Urology +17